z-logo
open-access-imgOpen Access
review on metabolic syndrome
Author(s) -
Manish Kumar Gupta,
Ketaki Dhane,
Birendra Shrivasttva,
Supriya Hyam,
Sujit Nagare,
Abhinandan Patil
Publication year - 2022
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns2.6507
Subject(s) - metabolic syndrome , dyslipidemia , medicine , diabetes mellitus , immune system , inflammation , disease , malnutrition , obesity , immunology , dysbiosis , bioinformatics , endocrinology , biology
Metabolic syndrome is considered a major reason for the emergence of chronic dreadful diseases. Obesity and wrong food habit are key factors for metabolic syndrome. Globally people are affected by glucose intolerance, central obesity, hypertension, and dyslipidemia. Diabetes is a major part of metabolic syndrome. Targeted anti-inflammatory therapy has been suggested for both prevention and treatment of many of the above-said syndrome especially diabetes. Diet is an important regulatory factor in the immune response. There is considerable evidence to suggest that malnutrition leads to immune suppression due to a susceptibility to infection. On the other hand, over-nutrition leads to immune activation due to a susceptibility to an inflammatory condition. Inflammation may have an important role in the development and progression of diabetes and its complications; however, the impact of experimental anti-inflammatory treatments on diabetes deterioration over time and cardiovascular outcomes is still elusive. Thus proper diet with some drug therapy not only resolves the issue but can prevent the progression of the disease at extreme levels.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here